1 / 17

Nocosomial infection with Vancomycin-dependent Enterococci

Nocosomial infection with Vancomycin-dependent Enterococci. Michelle Nguyen Bioc 230 10/11/04. Preview. Cases Molecular profiling of VDE Case control study Discussion. Case 1. 32 y.o woman with h/o type 1 DM, ESRD Kidney-pancreas transplant

luna
Download Presentation

Nocosomial infection with Vancomycin-dependent Enterococci

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Nocosomial infection with Vancomycin-dependent Enterococci Michelle Nguyen Bioc 230 10/11/04

  2. Preview • Cases • Molecular profiling of VDE • Case control study • Discussion

  3. Case 1 • 32 y.o woman with h/o type 1 DM, ESRD • Kidney-pancreas transplant • Post-op infection with VR Enterococcus faeciumTx with antibiotics • Abdominal fluid culture VR E. faecium that cannot grow w/o Vancomycin • Refractory sepsisdeath (day 268)

  4. Case #2 • 40 y.o woman with h/o type I DM, ESRD • Kidney-pancreas transplant • Post-op: VRE from intraabdominal culturesremove kidney and pancreas • Antibiotic tx with IV streptogramins • Refractory VREdeath

  5. Case #3 • 47 y.o woman with h/o CML • Matched-unrelated donor bone marrow transplant • Post-op: severe GVHD, acute renal failure, bacteremia with Corynebacteriumvancomycin • UTI with VREnot eradicated • Death due to refractory GVHD with multiple organ failure (day 87)

  6. Tip off: what are the common points • Nocosomial infections • Comorbidities: DM, kidney dysfunction,tranplants post-op complications • Bacteremia with VDE • Broad use of antibiotics and immunosuppressive drugs (what are the risks??)

  7. Characterizing VDE • Criteria • VRE: growth in 6ug/ml Vancomycin, MIC>8ug/ml Vanco • VDE: cannot growth without 6ug/ml Vanco with multiple subcultures • Molecular profile • Susceptibility testing: Vanco disk, D-ala-D-ala disk • Resistance gene vanA and vanB: PCR • Strain relation (distinct clones?): Pulsed-field gel electrophoresis (PFGE) • Spontaneous reversion from VDE to VRE: serial dilutions of culture grown in Vanco+ broth to Vanco+/- agar plates

  8. Susceptibility Test Result Revertant VDE

  9. PFGE

  10. Molecular profile of VDE • Strain: E. faecium • Resistance gene: vanA (2), vanB (1) • Resistance profile: penicillins, gentamicin, erythromycin • Susceptibility: streptogramins, teicoplanin • Spontaneous reversion: around 1x10-6 except for strain 3 (2.6x10-3) • Growth not supported by D-ala-D-ala

  11. Proposed mechanism for Vancomycin dependence • Loss of D-ala-D-ala ligase in VRE strain • Vancomycin induces production of D-ala-D-lactate ligase • Require prolonged exposure to Vancomycin

  12. Case control study • 3 patients with nocosomial VDE infection • 10 patients with nocosomial VRE infection • 10 at-risk patients not infected with enterococci • Matched by age and admission to same service

  13. Typical case control study design

  14. Case study results

  15. Specific findings • Length of exposure to antimicrobials • Vancomycin • 3rd generation cephalosporins • Mortality • Gender • Exposure to ICU

  16. Possible risk factors • Intense use of 3rd generation cephalosporins • Renal insufficiency • Spontaneous reversionVanco discontinuation might not be sufficient to treat VDE infection.

More Related